References
- Bonaglia MC, Giorda R, Massagli A, Galluzzi R, Ciccone R, Zuffardi O. A familial inverted duplication/ deletion of 2p25.1-25.3 provides new clues on the genesis of inverted duplications. Eur J Hum Genet. 2009; 17(2): 179-186.
- Aviram-Goldring A, Fritz B, Bartsch C, Steuber E, Daniely M, Lev D, et al. Molecular cytogenetic studies in three patients with partial trisomy 2p, including CGH from paraffin-embedded tissue. Am J Med Genet. 2000; 91(1): 74-82.
- Lee C, Murray MF, Miron OM, Marsden D, Irons M, Wilkins-Haug LE, et al. Clinical picture: Multicolour karyotyping. Lancet. 2001; 357(9264): 1240.
- Sperry ED, Schuette JL, van Ravenswaaij-Arts CMA, Green GE, Martin DM. Duplication 2p25 in a child with clinical features of CHARGE syndrome. Am J Med Genet A. 2016; 170A(5): 1148-1154.
- Malmgren H, Sahlén S, Wide K, Cundvall M, Blennow E. Distal 3p Syndrome: Detailed molecular cytogenetic and clinical characterization of three small distal deletions and review. Am J Med Genet. 2007; 143(18): 2143-2149.
- Moghadasi S, Haeringen A, Langerdonck L, Gijsbers ACJ, Ruivenkamp CAL. A terminal 3p26.3 deletion is not associated with dysmorphic features and intellectual disability in a four-generation family. Am J Med Genet A. 2014; 164A(11): 2863-2868.
- Chen C-P, Liu F-F, Jan S-W, Lin S-P, Lan C-C. Prenatal diagnosis of partial monosomy 3p and partial trisomy 2p in fetus associated with shortening of the long bones and a single umbilical artery. Prenat Diagn. 1996; 16(?): 270-275.
- Wakita Y, Narahara K, Takahashi Y, Kikkawa K, Kimura S, Oda M, et al. Duplication of 2p25: Confirmation of the assignment of soluble acid phosphatise (ACP1) locus to 2p25. Hum Genet. 1985; 71(3): 259-260.
- Roggenbuck JA, Fink JM, Mendelsohn NJ. Unique case of trisomy 2p24.3-pter with no associated monosomy. Am J Med Genet. 2001; 101(1): 50-54.
- Tsurusaki Y, Koshimizu E, Ohashi H, Phadke S, Kou I, Shiina M, et al. De novo SOX11 mutations cause Coffin-Siris syndrome. Nat Commun. 2014; 5: 4011.
- De Rocker N, Vergult S, Koolen D, Jacobs E, Hoischen A, Zeesman S, et al. Refinement of the critical 2p25.3 deletion region: The role of MYT1L in intellectual disability and obesity. Genet Med. 2015; 17(6): 460-466.
- Lund ICB, Christensen R, Petersen OB, Vogel I, Vestergaard EM. Chromosomal microarray in foetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 2015; 45(1): 95-100.
- Thangavelu M, Frolich G, Rogers D. Partial duplication 2p as the sole abnormality in two cases with anencephaly. Am J Med Genet A. 2004; 124A(2): 170-172.
- Marlet L, Alix E, Till M, Raskin-Champion F, Attia J, Boggio D, et al. Prenatal diagnosis of trisomy 2p due to terminal 2p duplication including interstitial telomeric sequences. Cytogenet Genome Res. 2017; 153(3): 117-124.
- Kuechler A, Zink AM, Wieland T, Lüdecke H-J, Cremer K, Salviati L, et al. Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome. Eur J Hum Genet. 2015; 23(6): 753-760.
- Mattioli F, Schaefer E, Magee A, Mark P, Mancini M, Dieterich K, et al. Mutations in histone acetylase modifier BRPF1 cause an autosomal-dominant form of intellectual disability with associated ptosis. Am J Hum Genet 2017; 100(1): 105-116.
- Fernandez T, Morgan T, Davis N, Klin A, Morris A, Farhi A, et al. Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet. 2004; 74(6): 1286-1293.
- Suzuki-Muromoto S, Hino-Fukuyo N, Haginoya K, Kikuchi A, Sato H, Sato Y, et al. A case of 3p deletion syndrome associated with cerebellar hemangioblastoma. Brain Dev. 2015; 2(2): 257-206.
- Pohjola P, De Leeuw N, Penttinen M, Kääriäinen H. Terminal 3p deletions in two families - Correlation between molecular karyotype and phenotype. Am J Med Genet A. 2010; 152A(2): 441–446.
- Cuoco C, Ronchetto P, Gimelli S, Béna F, Divizia MT, Lerone M, et al. Microarray based analysis of an inherited terminal 3p26.3 deletion, containing only the CHL1 gene, from a normal father to his two affected children. Orphanet J Rare Dis. 2011; 6: 12.
- Cargile CB, Goh DL-M, Goodman BK, Chen X-N, Korenberg JR, Semenza GL, et al. Molecular cytogenetic characterization of subtle interstitial del(3) (p25.3-p26.2) in patient with 3p syndrome. Am J Med Genet. 2002; 109(2): 133-138.
- Carvill GL, Jacinta M, McMahon JM, Schneider A, Zemel M, Myers CT, et al. Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonicatonic seizures. Am J Hum Genet. 2015; 96(5): 808-815.
- Shuib S, McMullan D, Rattenberry E, Barber RM, Rahman F, Zatyka M, et al. Microarray based analysis of 3p25-p26 deletions (3p-syndrome). Am J Med Genet A. 2009; 149A(10): 2099-2105.
- Robinson SW, Morris CD, Goldmuntz E, Reller MD, Jones MA, Steiner RD, et al. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet. 2003; 72(4): 10471052.
- Sotgia F, Minetti C, Lisanti MP. Localization of the human caveolin-3 gene to the D3S18/D3S4163/ D3S4539 locus (3p25), in close proximity to the human oxytocin receptor gene. Identification of the caveolin-3 gene as a candidate for deletion in 3psyndrome. FEBS Lett. 1999; 452(3): 177-180.
- Peltekova IT, Macdonald A, Armour C. Microdeletion on 3p25 in a patient with features of 3p deletion syndrome. Am J Med Genet A. 2012; 158A(10): 2583-2586.
- Chen C-P, Su Y-N, Chen C-Y, Su J-W, Chern S-R, Town D-D, et al. Pure partial monosomy 3p (3p25.3→ pter): Prenatal diagnosis and array comparative genomic hybridization characterization. Taiwan J Obstet Gynecol. 2012; 51(3): 435-439.
- Chen C-P, Chen Y-Y, Chern S-R, Wu P-S, Su J-W, Chen W-L, et al. Prenatal diagnosis of a distal 3p deletion associated with fetoplacental chromosomal discrepancy and confined placental mosaicism detected by array comparative genomic hybridization. Taiwan J Obstet Gynecol. 2013; 52(2): 278-284.
- Mack LM, Lee W, Mastrobattista JM, Belfort MA, Van den Veyver IB, Shamshirsaz AA, et al. Are first trimester nuchal septations independent risk factors for chromosomal anomalies? J Ultrasound Med. 2017; 36(1): 155-161.
- Khalil A, Mahmoodian N, Kulkarni A, Homfray T, Papageorghiou A, Bhide A, et al. Estimation of detection rates of aneuploidy in high-risk pregnancy using an approach based on nuchal translucency and non-invasive prenatal testing: A cohort study. Fetal Diagn Ther. 2015; 38(4): 254-261.
- Grande M, Jansen FA, Blumenfeld YJ, Fisher A, Odibo AO, Haak MC, et al. Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: A systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015; 46(6): 650-658.